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The gastrointestinal (GI) tracts of non-human primates (NHPs) are well known to harbor
Escherichia coli, a known commensal of human beings and animals. While E. coli is a nor-
mal inhabitant of the mammalian gut, it also exists in a number of pathogenic forms or
pathotypes, including those with predisposition for the GI tract as well as the urogenital
tract. Diarrhea in captive NHPs has long been a problem in both zoo settings and research
colonies, including the Como Zoo. It is an animal welfare concern, as well as a public health
concern. E. coli has not been extensively studied; therefore, a study was performed during
the summer of 2009 in collaboration with a zoo in Saint Paul, MN, which was previously
experiencing an increased incidence and severity of diarrhea among their NHP collection.
Fresh fecal samples were collected weekly from each member of the primate collection,
between June and August of 2009, and E. coli were isolated. A total of 33 individuals were
included in the study, representing eight species. E. coli isolates were examined for their
genetic relatedness, phylogenetic relationships, plasmid replicon types, virulence gene
profiles, and antimicrobial susceptibility profiles. A number of isolates were identified con-
taining virulence genes commonly found in several different E. coli pathotypes, and there
was evidence of clonal transmission of isolates between animals and over time. Overall,
the manifestation of chronic diarrhea in the Como Zoo primate collection is a complex prob-
lem whose solution will require regular screening for microbial agents and consideration
of environmental causes. This study provides some insight toward the sharing of enteric
bacteria between such animals.
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INTRODUCTION
Escherichia coli is a Gram-negative bacteria and known gut com-
mensal of animals, including non-human primates (NHPs) (1–
11). This diverse organism not only plays a role in the maintenance
of gut health by helping to prevent the establishment of pathogenic
bacteria in the gastrointestinal (GI) tract, but can also exist in a
number of pathogenic forms (5, 12). In fact, pathogenic forms of
E. coli are a major cause of diarrheal illness worldwide (13, 14). In
addition, E. coli is a model laboratory organism, which has been
used to examine basic evolutionary processes, bacterial patho-
genesis, and epidemiological transmission (14–17). The ubiquity
and ease of isolation of E. coli have enabled ecological studies to
investigate how anthropogenic change (e.g., forest fragmentation)
affects bacterial transmission among wildlife, including primates,
human beings, and livestock (18–21). Information generated from
these types of studies provides insight into the disease transmis-
sion process, enabling for the calculation of potential risk factors
associated with human encroachment on wildlife populations and
vice versa (18–21). Such studies also aid in the development and
implementation of conservation strategies to protect endangered
wildlife (18–21).
Diarrhea in captive primates has long been a problem in both
zoo settings and research colonies (22–28). In fact, since at least
1998, the primate collection at the Como Zoo in Saint Paul, MN,
has experienced issues with diarrhea. Diarrhea is a medical con-
cern not only because it is physiologically taxing to the animals,
but also because it is an ideal mechanism for disease transmission,
making it both a public health concern and an animal welfare
concern. Management of intermittent diarrhea is confounded by
its complexities, including the lack of a consistently identifiable
causative agent.
In many animals, including primates, some pathotypes of E. coli
such as enteropathogenic E. coli (EPEC) are associated with the
development of persistent diarrhea (3, 7, 29). Although the E. coli
pathotypes have been clearly defined, they often differ in virulence
between hosts, even between closely related mammals (21, 30, 31).
For example, one of the most pathogenic forms of E. coli toward
human beings is Shiga toxin-producing E. coli, or STEC, which
includes serotype 0157:H7. STEC are commensal organisms in
ruminants, but are highly virulent pathogens in human beings that
can cause severe hemorrhagic colitis (32–34). In NHPs, it is unclear
whether certain pathotypes exist as commensals or pathogens.
In this study, we examined E. coli isolates from 33 NHPs within
a single zoo over a 7-week period, surveying genetic related-
ness using a sequence-based approach, phylogenetic types, plas-
mid replicon types, virulence gene profiles, and antimicrobial
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susceptibility profiles. E. coli was the organism most suited for
the purposes of this study, as it is easily culturable, has been
previously implicated in episodes of diarrheal illness in captive
primate populations, and is an ideal organism to assess genetic
relatedness and microbial gene flow. The goal of this work was
to determine whether primates are in fact a reservoir for E. coli
harboring virulence genes and plasmid types typical of different
E. coli pathotypes, to determine the genetic relatedness of E. coli
over time and between co-habitating (i.e., same primate complex)
animal groups, to assess the antimicrobial susceptibilities of E. coli
isolates, and to evaluate the potential link between the zoo’s history
of diarrhea with pathogenic E. coli presence.
MATERIALS AND METHODS
PRIMATE STUDY POPULATION AND FECAL SAMPLE COLLECTION
The research in this study complied with protocols approved
through the University of Minnesota Institutional Animal Care
and Use Committee. The primate collection at the Como Zoo
in Saint Paul, MN, an American Zoological Association (AZA)
accredited zoo, served as the study population, which included
33 healthy primates representing eight primate species (Table 1).
Fresh fecal samples were collected weekly from each primate,
between June and August of 2009. Samples were collected from
freshly voided feces using a sterile spatula, with care to collect
from the top of the sample to avoid ground contamination. After
collection, samples were immediately placed on ice for transport
from the zoo to the laboratory and subsequently processed.
BACTERIAL ISOLATES
E. coli isolates (N = 162) were included in this study. E. coli was
isolated from fecal samples as follows: 1 g of fresh fecal mater-
ial was homogenized in 10 mL of buffered peptone water (BD,
Sparks, MD, USA). Ten-fold serial dilutions were performed on
each sample, and dilutions were plated on MacConkey agar (BD).
Table 1 | Primate populations included in this study.
Animal ID Common name Scientific name Sex Age (years, as of 2009)
WLG1 Western lowland gorilla G. gorilla gorilla Male 24
WLG2 Western lowland gorilla G. gorilla gorilla Male 23
WLG3 Western lowland gorilla G. gorilla gorilla Male 21
O1 Orangutan P. sp. hybrid Female 33
O2 Orangutan P. abelii Male 24
O3 Orangutan P. abelii Female 22
O4 Orangutan P. abelii Male 2
DM1 De Brazza’s monkey C. neglectus Female 12
DM2 De Brazza’s monkey C. neglectus Male 11
BHSM1 Black-handed spider monkey A. geoffroyi Male 19
BHSM2 Black-handed spider monkey A. geoffroyi Male 18
BHSM3 Black-handed spider monkey A. geoffroyi Female 18
BHSM4 Black-handed spider monkey A. geoffroyi Female 18
BHSM5 Black-handed spider monkey A. geoffroyi Female 13
WFS1 White-faced saki P. pithecia Male 9
WFS2 White-faced saki P. pithecia Female 11
WFS3 White-faced saki P. pithecia Male 4
WFS4 White-faced saki P. pithecia Male 3
WFS5 White-faced saki P. pithecia Female 1
BEBL1 Blue-eyed black lemur E. macaco flavifrons Male 15
BEBL2 Blue-eyed black lemur E. macaco flavifrons Female 12
ET1 Emperor tamarin S. imperator subgrisescens Male 21
ET2 Emperor tamarin S. imperator subgrisescens Female 11
ET3 Emperor tamarin S. imperator subgrisescens Male 2
ET4 Emperor tamarin S. imperator subgrisescens Female 2
ET5 Emperor tamarin S. imperator subgrisescens Male 2
ET6 Emperor tamarin S. imperator subgrisescens Male 2
ET7 Emperor tamarin S. imperator subgrisescens Male 17
ET8 Emperor tamarin S. imperator subgrisescens Female 12
ET9 Emperor tamarin S. imperator subgrisescens Male 3
ET10 Emperor tamarin S. imperator subgrisescens Male 3
GT1 Geoffroy’s tamarin S. geoffroyi Male 12
GT2 Geoffroy’s tamarin S. geoffroyi Female 9
G.: Gorilla; P.: Pongo; C.: Cercopithecus; A.: Ateles; P.: Pithecia; E.: Eulemur; S.: Saguinus.
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Plates with isolated colonies were used to pick one presump-
tive colony per fecal sample. Suspect E. coli colonies were then
re-plated on Levine eosin methylene blue (EMB) agar (BD) as
a secondary confirmation of E. coli. Finally, the suspect E. coli
colonies from the EMB agar were confirmed using PCR primers
specific for E. coli (35).
DNA EXTRACTION AND PCR ANALYSIS
DNA templates for PCR were prepared using boiled lysates of
overnight cultures from each individual sample being examined
(36). A total of 22 E. coli control strains were used in this study
(Table S1 in Supplementary Material). For plasmid replicon typing
and virulence gene screening, amplifications were performed in a
25µL reaction mixture, containing 5µL 5× PCR buffer (Promega,
Madison, WI, USA), 0.25 mM dNTP mixture, 2.5 U Taq DNA
polymerase (Promega), 0.15µmol of each primer, and 2µL tem-
plate DNA. Following PCR (described below), the samples were
subjected to horizontal gel electrophoresis in a 2.0% (w/v) Tris–
acetate–EDTA (TAE) agarose, and the size of the amplicons was
determined by comparison to the 100 bp DNA marker and known
positive controls (New England Biolabs, Beverly, MA, USA).
PHYLOGENETIC GROUP TYPING
Isolates were assigned to one of the four phylogenetic groups
(A, B1, B2, or D) using the interpretive approach of Clermont
et al. (37). As determined by PCR, isolates were assigned to
groups based on their possession of two genes (chuA and yjaA)
and a DNA fragment (TSPE4.C2).
SEQUENCE-BASED TYPING
A subset of isolates was examined for genetic relatedness using
fumC gene sequencing, as previously described (38). For each iso-
late, PCR amplicons were generated and subjected to bidirectional
sequencing using the same PCR primers used for amplification.
Resulting sequences were quality trimmed, assembled, and con-
catenated to a similar size. Phylogenetic relationships between the
isolates were examined using MEGA5 (39). Data from this project
are freely available at Figshare (http://figshare.com/articles/Zoo_
E_coli_fumC_dataset/956237).
VIRULENCE GENOTYPING
Test and control organisms were examined for the presence of
10 genes known for their association with Extraintestinal patho-
genic E. coli (ExPEC) virulence: cvaC, etsB, hlyA, hlyF, ireA, iroN,
iss, iutA, papC, and sitA (40, 41); three genes associated with EPEC
virulence: eae, espC, and tir ; three genes associated with Enterotox-
igenic E. coli (ETEC) virulence: eltA, sta, and stb; three genes asso-
ciated with Enterohemorrhagic E. coli (EHEC) virulence: etpD,
stx1A, and stx2A; three genes associated with Enteroaggregative E.
coli (EAEC) virulence: aatP, aggR, and pet; and two genes associ-
ated with Enteroinvasive E. coli (EIEC) virulence: sepA and shET2.
The multiplex procedures for the majority of ExPEC-associated
genes screened for in this study are previously described (40).
Three additional multiplex PCR assays were designed in this study
to screen for the remainder of genes (Table S2 and Figure S1 in
Supplementary Material). Reaction mixtures associated with the
three multiplex PCR assays designed in this study were subjected
to the following cycling parameters: initial denaturation (95°C,
10 min), followed by 30 cycles of denaturation (94°C, 30 s), anneal-
ing (55°C, 30 s), and extension (72°C, 60 s), and a final extension
(72°C, 7 min). Specificity of the primers was confirmed using
known positive and negative bacterial controls.
PLASMID REPLICON TYPING
Isolates were examined for the presence of 15 sequences specific
for different plasmid incompatibility types using a combination
of multiplex PCR assays previously described (42). The follow-
ing plasmid incompatibility groups were sought: IncP-1α, IncA/C,
IncFIC, IncB/O, IncK/B, IncW, IncFIA, IncFIB, IncY, IncI1, IncX,
IncHI1, IncN, IncHI2, and IncL/M.
ANTIMICROBIAL SUSCEPTIBILITY TESTING
E. coli isolates (N = 162) were tested for susceptibility to seven
antimicrobial agents by Kirby-Bauer disk diffusion, according to
the Clinical Laboratory Standards Institute (CLSI) MIC Interpre-
tative Standards using Mueller–Hinton agar plates (43, 44). Disks
containing the following antimicrobial agents were used: ampi-
cillin (AM, 10µg), gentamicin (GM, 10µg), nalidixic acid (NA,
30µg), streptomycin (S, 10µg), tetracycline (TE, 30µg), sulfisox-
azole (G, 0.25 mg) and trimethoprim (TMPS or W5, 5µg) (BD).
The following E. coli strains were used as positive controls: ATCC
25922 and APEC 01 (43–45).
RESULTS
Over the course of this seven-week study, a total of 229 fecal
samples were collected from the Como Zoo’s primate collection.
Of the 229 fecal samples collected, E. coli was successfully iso-
lated from 162 samples (70.7%). Unsuccessful isolations typically
involved overgrowth with Proteus spp. which was unable to be
resolved. For the E. coli isolates (N = 162) used in this study,
one colony per sample was selected. The majority of the indi-
viduals were sampled weekly throughout the seven-week study
period (i.e., seven total samples collected per individual). How-
ever, there were two instances where an individual was not sampled
due to unavailable sample material during the designated sample
collection period.
PHYLOGENETIC GROUP TYPING
Phylogenetic groups A, B1, B2, and D were all found to be present
in the captive population of NHPs tested in this study. Of the
four phylogenetic groups tested for in this study, B1 was the most
commonly identified group, with 53.1% (N = 86) of the isolates
testing positive. In addition, 22.8% (N = 37) of the isolates tested
positive for group A and 19.8% (N = 32) of the isolates tested pos-
itive for group B2. The least prevalent phylogenetic group in this
study was group D, which tested positive in 4.3% (N = 7) of the
isolates.
SEQUENCE-BASED TYPING
Sequence-based typing was performed on a subset (N = 91) of the
E. coli isolates, selected to be representative of the total population
based upon date of isolation and animal source, using the fumC
gene (Figure 1). A total of 18 fumC sequence types were identified
using the Achtman E. coli MLST database (46). Sequence types
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FIGURE 1 | Results of resistance phenotyping, plasmid replicon
analysis, virulence genotyping, and fumC sequence analysis
among 91 isolates in this study. Species are colored as follows:
orange: De Brazza’s monkey; light pink: orangutan; pink: emperor
tamarin; dark purple: spider monkey; light purple: white-faced saki; light
green: lemur; dark green: gorilla; and light blue: Geoffroy’s tamarin.
Dendrogram depicts relationships of isolates using fumC sequence
analysis.
spanned multiple isolates, species, and collection time points.
Some common patterns were observable, though. For example, in
many cases isolates were identified that originated from the same
animal at different time points, and possessed identical sequence
types as well as identical genotyping profiles, suggesting common
clones persisting over time. There was also evidence of transfer of
common E. coli clones between animals of the same species, and
between animals of differing species over time. In particular, the
following identical genotyping patterns were observed: fumC65
(two sets of two isolates), fumC29 (five isolates), fumC23 (two
sets of two isolates), fumC24 (four isolates), fumC43 (eight iso-
lates), fumC260 (three sets of two isolates), and fumC11 (two sets
of seven and five isolates).
PLASMID REPLICON TYPING
All eight NHP species examined were found to harbor E. coli
with DNA sequences associated with at least one of the 15
plasmid incompatibility groups sought in this study. Of the 15
plasmid incompatibility groups examined, 9 were found to be
present in the isolates, including IncFIB, IncI1, IncFIC, IncP-1α,
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Table 2 | Overall prevalence of each gene and plasmid replicon studied
(at least one positive isolate).
Gene/Replicon Prevalence (%) (N =162)
IncP-1α 6.8 (N = 11)
IncFIC 8.0 (N = 13)
IncB/O 3.7 (N = 6)
IncK/B 2.5 (N = 4)
IncW 0.6 (N = 1)
IncFIA 3.1 (N = 5)
IncFIB 25.3 (N = 41)
IncI1 14.2 (N = 23)
IncN 1.2 (N = 2)
hlyA 7.4 (N = 12)
papC 1.9 (N = 3)
sitA 19.8 (N = 32)
cvaC 8.6 (N = 14)
iroN 17.3 (N = 28)
hlyF 8.0 (N = 13)
etsB 1.9 (N = 3)
iss 10.5 (N = 17)
aerJ (iutA) 8.0 (N = 13)
ireA 1.9 (N = 3)
eae 13.0 (N = 21)
espC 8.0 (N = 13)
tir 9.3 (N = 15)
eltA 0.6 (N = 1)
sta 0.6 (N = 1)
pet 9.3 (N = 15)
stx1A 4.9 (N = 8)
etpD 2.5 (N = 4)
sepA 10.5 (N = 17)
shET2 1.2 (N = 2)
IncB/O, IncFIA, IncK/B, IncN, and IncW (Table 2). However, only
two plasmid types were prevalent among isolates at rates greater
than 10% (RepFIB and RepI1).
VIRULENCE GENOTYPING
Screening for 24 virulence factors associated with ExPEC, EPEC,
ETEC, EAEC, EHEC, and EIEC, all eight NHP species tested were
found to contain E. coli possessing known virulence factors. Of
these 24 virulence factors, 20 were identified in the E. coli isolates
from 31 of the 33 primates in this study.
Of the 10 ExPEC-associated genes sought, all were found to
be present in at least one NHP, including sitA, iroN, iss, cvaC,
hlyF, iutA, hlyA, etsB, ireA, and papC (Table 2). Furthermore,
ExPEC-associated genes were found among E. coli isolated from
every NHP species examined (Table 3). In terms of gene func-
tion, ExPEC genes sought included those associated with iron
acquisition (sitA, iroN, iutA, ireA, and etsB), serum survival (iss),
colicin production (cvaC), hemolysin production (hlyA and hlyF),
and fimbriae production (papC) (40, 41, 47–50). Three ExPEC-
associated genes were present in greater than 10% of the isolates
examined: sitA (19.8%), iroN (17.3%), and iss (10.5%). These
genes often occurred together in the same isolates. At weeks 6 and
7 of sampling, ExPEC virulence genes had the highest prevalence
of all genes screened (Table 4).
Of the three EPEC-associated genes screened, all three were
present in at least one primate, including eae (N= 21), tir
(N= 15), and espC (N= 13) (Table 2). EPEC-associated genes
were present in six of eight primate species examined in this study,
including Old World monkeys, New World monkeys, and lemurs.
Isolates from only two species, gorillas, and orangutans, did not
harbor EPEC-associated genes. Both primate species are great
apes and belong to the same taxonomic family as humans (i.e.,
Hominidae) (Table 3). The most prevalent EPEC-associated gene,
eae (13.0%), which is required for attaching/effacing adherence
in E. coli (51, 52), was identified in isolates from the following
primate species: De Brazza’s monkeys, spider monkeys, white-
faced sakis, lemurs, emperor tamarins, and Geoffroy’s tamarins
(Table 4). The EPEC-associated gene, tir (9.3%), which plays a
role in adherence to small intestinal epithelial cells (51), was iden-
tified in isolates from the following primate species: De Brazza’s
monkeys, spider monkeys, white-faced sakis, lemurs, and emperor
tamarins (Table 4). The EPEC-associated gene,espC (8.0%),which
is responsible for the production of an autotransporter pro-
tein/enterotoxin (53), was identified in isolates from the following
primate species: De Brazza’s monkeys, white-faced sakis, lemurs,
and emperor tamarins (Table 3). The espC-encoded protein is
unique as it is the only one of the five proteins secreted extracellu-
larly that is secreted independently of the type III secretion system
encoded on the enterocyte effacement pathogenicity island (53).
Of the three ETEC-associated genes screened, sta and eltA
were present in at least one NHP albeit at very low prevalence
(Table 2), while stb was not found in any isolates examined. sta
and eltA are both enterotoxin-encoding genes (54). sta encoding
heat-stable toxin type A and eltA encoding heat-labile enterotoxin
A prepeptide gene (54).
Of the three EAEC-associated genes screened, only pet was
present in at least one primate, with an overall prevalence of 9.3%
(Table 2). Among the isolates analyzed via fumC sequencing, two
lineages of strains possessed pet, with or without co-carriage of
ExPEC virulence genes and/or sepA (Figure 1). Some of these iso-
lates possessed an IncI1 plasmid, which is characteristic of EAEC
strains possessing a virulence plasmid (55). The EAEC-associated
gene pet is an autotransporter enterotoxin gene that contributes
to diarrheal illness, which is predominantly secretory in nature,
seen in patients with EAEC (56). Specifically, pet was found in the
gorillas, spider monkeys, white-faced sakis, and emperor tamarins
(Table 3).
Of the three EHEC-associated genes screened, stx1A and etpD
were present in at least one primate (Table 2). stx2a was not
found in any isolates. The most prevalent EHEC-associated gene,
stx1A (4.9%), was identified in isolates from the following primate
species: De Brazza’s monkeys, spider monkeys, white-faced sakis,
and emperor tamarins (Table 3).
Of the two EIEC-associated genes screened, both were present
in at least one primate, including sepA and shET2 (Table 2).
The most prevalent EIEC-associated gene, sepA (10.5%), was
identified in isolates from the following primate species: De
Brazza’s monkeys, spider monkeys, white-faced sakis, lemurs, and
emperor tamarins (Table 3). The EIEC-associated gene sepA
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Table 3 | Prevalence of each gene and plasmid replicon studied by primate species.
Gene/Replicon Gorilla Orangutan De Brazza’s
Monkey
Spider
Monkey
White-faced
Saki
Lemur Emperor
Tamarin
Geoffroy’s
Tamarin
Prevalence of genes screened by primate species (at least one positive isolate)
IncP-1α 10.5% (2) 14.8% (4) 0.0% (0) 0.0% (0) 11.1% (3) 0.0% (0) 6.5% (2) 0.0% (0)
IncFIC 5.3% (1) 0.0% (0) 16.7% (2) 0.0% (0) 18.5% (5) 20.0% (1) 16.1% (5) 0.0% (0)
IncB/O 5.3% (1) 0.0% (0) 0.0% (0) 2.9% (1) 7.4% (2) 0.0% (0) 6.5% (2) 0.0% (0)
IncK/B 10.5% (2) 3.7% (1) 0.0% (0) 2.9% (1) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
IncW 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 3.2% (1) 0.0% (0)
IncFIA 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 14.8% (4) 20.0% (1) 0.0% (0) 0.0% (0)
IncFIB 21.1% (4) 37.0% (10) 0.0% (0) 17.6% (6) 48.1% (13) 40.0% (2) 9.7% (3) 42.9% (3)
IncI1 0.0% (0) 0.0% (0) 33.3% (4) 44.1% (15) 11.1% (3) 0.0% (0) 9.7% (3) 0.0% (0)
IncN 5.3% (1) 3.7% (1) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
hlyA 47.4% (9) 3.7% (1) 0.0% (0) 2.9% (1) 0.0% (0) 0.0% (0) 3.2% (1) 0.0% (0)
papC 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 9.7% (3) 0.0% (0)
sitA 57.9% (11) 22.2% (6) 8.3% (1) 14.7% (5) 7.4% (2) 0.0% (0) 12.9% (4) 42.9% (3)
cvaC 0.0% (0) 33.3% (9) 0.0% (0) 0.0% (0) 3.7% (1) 20.0% (1) 0.0% (0) 42.9% (3)
iroN2 57.9% (11) 37.0% (10) 0.0% (0) 0.0% (0) 7.4% (2) 20.0% (1) 9.7% (3) 28.6% (2)
hlyF2 5.3% (1) 33.3% (9) 0.0% (0) 0.0% (0) 7.4% (2) 20.0% (1) 0.0% (0) 0.0% (0)
etsB 0.0% (0) 7.4% (2) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 14.3% (1)
iss 5.3% (1) 25.9% (7) 0.0% (0) 2.9% (1) 14.8% (4) 20.0% (1) 3.2% (1) 28.6% (2)
iutA 36.8% (7) 0.0% (0) 0.0% (0) 2.9% (1) 14.8% (4) 0.0% (0) 3.2% (1) 0.0% (0)
ireA 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 9.7% (3) 0.0% (0)
eae 0.0% (0) 0.0% (0) 25.0% (3) 11.8% (4) 11.1% (3) 20.0% (1) 29.0% (9) 28.6% (2)
espC 0.0% (0) 0.0% (0) 25.0% (3) 0.0% (0) 3.7% (1) 20.0% (1) 29.0% (9) 0.0% (0)
tir 0.0% (0) 0.0% (0) 25.0% (3) 8.8% (3) 3.7% (1) 20.0% (1) 25.8% (8) 0.0% (0)
eltA 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 3.2% (1) 0.0% (0)
sta 0.0% (0) 0.0% (0) 8.3% (1) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
pet 31.6% (6) 0.0% (0) 0.0% (0) 5.9% (2) 18.5% (5) 0.0% (0) 6.5% (2) 0.0% (0)
stx1A 0.0% (0) 0.0% (0) 25.0% (3) 2.9% (1) 11.1% (3) 0.0% (0) 6.5% (2) 0.0% (0)
etpD 0.0% (0) 0.0% (0) 0.0% (0) 8.8% (3) 3.7% (1) 0.0% (0) 0.0% (0) 0.0% (0)
sepA 0.0% (0) 0.0% (0) 25.0% (3) 5.9% (2) 18.5% (5) 20.0% (1) 22.6% (7) 0.0% (0)
shET2 0.0% (0) 0.0% (0) 16.7% (2) 0.0% (0) 0.0% (0) 0.0% (0) 3.2% (1) 0.0% (0)
encodes a serine protease (57). The remaining EIEC-associated
gene shET2 (1.2%) was identified in the De Brazza’s monkeys and
emperor tamarins only. The EIEC-associated gene shET2 encodes
an enterotoxin (58). E. coli isolated from the gorillas, orangutans,
and Geoffroy’s tamarins did not harbor any EIEC-associated genes
(Table 3).
ANTIMICROBIAL SUSCEPTIBILITY TESTING
Based on the disk diffusion results, the majority of isolates were
susceptible to the seven antibiotics tested (Table 5). However, there
were isolates displaying individual or combined decreased antibi-
otic susceptibility to six of the seven antibiotics tested. Of the
antibiotics tested in this study, isolates were most commonly resis-
tant to ampicillin (17.9%) and tetracycline (14.2%). The remain-
ing antibiotics tested had lower occurrence of resistance among
the isolates tested (Table 5). Of the eight primate species screened
in this study, E. coli isolated from feces of De Brazza’s monkeys
showed the highest prevalence of ampicillin resistance (33.3%)
and E. coli isolated from feces of emperor tamarins showed the
highest prevalence of tetracycline resistance (41.9%) (Table 5).
In contrast, the Geoffroy’s tamarins were fully susceptible to all
seven antibiotics tested for the duration of the study. There were
nine isolates displaying multidrug resistance, defined as decreased
antibiotic susceptibility to >3 classes of antibiotics (59). Five of
27 isolates from white-faced sakis tested were multidrug resis-
tant, which was the most of any primate species tested in this
study.
DISCUSSION
For this study, we aimed to determine the prevalence of pathogenic
E. coli in a captive population of NHPs, to determine the genetic
relatedness of E. coli over time and between co-habitating (i.e.,
same primate complex) animal groups, to examine the antimi-
crobial susceptibility profiles of E. coli isolates, and to assess the
potential link between the zoo’s history of diarrhea with patho-
genic E. coli presence. E. coli was the organism most suited for the
purposes of this study, as it is easily cultured, has been previously
associated with diarrheal illness in captive primate populations,
and enables assessment of genetic relatedness and microbial gene
flow. Initially, we used a phylogenetic typing method to classify the
E. coli isolates into four groups (A, B1, B2, and D) (37). Of the four
phylogenetic groups, B1 is the group most commonly associated
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Table 4 | Prevalence of gene and plasmid replicon among the whole population over time.
Gene/Replicon Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7
Prevalence of genes and plasmid replicons screened by study week (at least one positive isolate)
IncP-1α 0.0% (0) 0.0% (0) 20.8% (5) 0.0% (0) 26.1% (6) 0.0% (0) 0.0% (0)
IncFIC 5.0% (1) 4.8% (1) 8.3% (2) 18.2% (4) 8.7% (2) 3.2% (1) 9.5% (2)
IncB/O 0.0% (0) 0.0% (0) 20.8% (5) 0.0% (0) 4.3% (1) 0.0% (0) 0.0% (0)
IncK/B 0.0% (0) 0.0% (0) 4.2% (1) 0.0% (0) 13.0% (3) 0.0% (0) 0.0% (0)
IncW 5.0% (1) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
IncFIA 0.0% (0) 4.8% (1) 4.2% (1) 9.1% (2) 0.0% (0) 3.2% (1) 0.0% (0)
IncFIB 10.0% (2) 42.9% (9) 33.3% (8) 59.1% (13) 17.4% (4) 12.9% (4) 4.8% (1)
IncI1 15.0% (3) 4.8% (1) 12.5% (3) 13.6% (3) 30.4% (7) 9.7% (3) 14.3% (3)
IncN 0.0% (0) 0.0% (0) 4.2% (1) 0.0% (0) 4.3% (1) 0.0% (0) 0.0% (0)
hlyA 0.0% (0) 14.3% (3) 16.7% (4) 4.5% (1) 8.7% (2) 6.5% (2) 0.0% (0)
papC 0.0% (0) 4.8% (1) 4.2% (1) 4.5% (1) 0.0% (0) 0.0% (0) 0.0% (0)
sitA 10.0% (2) 28.6% (6) 29.2% (7) 18.2% (4) 13.0% (3) 12.9% (4) 28.6% (6)
cvaC 0.0% (0) 19.0% (4) 8.3% (2) 18.2% (4) 8.7% (2) 6.5% (2) 0.0% (0)
iroN 20.0% (4) 28.6% (6) 20.8% (5) 22.7% (5) 17.4% (4) 12.9% (4) 4.8% (1)
hlyF 5.0% (1) 14.3% (3) 8.3% (2) 9.1% (2) 8.7% (2) 6.5% (2) 4.8% (1)
etsB 0.0% (0) 4.8% (1) 0.0% (0) 9.1% (2) 0.0% (0) 0.0% (0) 0.0% (0)
iss 5.0% (1) 14.3% (3) 12.5% (3) 22.7% (5) 8.7% (2) 6.5% (2) 4.8% (1)
iutA 5.0% (1) 19.0% (4) 12.5% (3) 4.5% (1) 8.7% (2) 3.2% (1) 4.8% (1)
ireA 0.0% (0) 4.8% (1) 4.2% (1) 4.5% (1) 0.0% (0) 0.0% (0) 0.0% (0)
eae 20.0% (4) 4.8% (1) 16.7% (4) 9.1% (2) 17.4% (4) 3.2% (1) 23.8% (5)
espC 25.0% (5) 0.0% (0) 12.5% (3) 0.0% (0) 13.0% (3) 3.2% (1) 4.8% (1)
tir 15.0% (3) 0.0% (0) 16.7% (4) 9.1% (2) 17.4% (4) 3.2% (1) 4.8% (1)
eltA 5.0% (1) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
sta 0.0% (0) 4.8% (1) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
pet 5.0% (1) 14.3% (3) 16.7% (4) 18.2% (4) 8.7% (2) 3.2% (1) 0.0% (0)
stx1A 5.0% (1) 4.8% (1) 8.3% (2) 0.0% (0) 4.3% (1) 9.7% (3) 0.0% (0)
etpD 0.0% (0) 4.8% (1) 4.2% (1) 9.1% (2) 0.0% (0) 0.0% (0) 0.0% (0)
sepA 10.0% (2) 9.5% (2) 16.7% (4) 13.6% (3) 17.4% (4) 3.2% (1) 4.8% (1)
shET2 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 8.7% (2) 0.0% (0) 0.0% (0)
Table 5 | Prevalence of antibiotic resistance by primate species (N ).
Antibiotic Gorilla Orangutan De Brazza’s
Monkey
Spider
Monkey
White-faced
Saki
Lemur Emperor
tamarin
Geoffroy’s
tamarin
Ampicillin 10.5% (2) 11.1% (3) 33.3% (4) 5.9% (2) 29.6% (8) 0.0% (0) 32.3% (10) 0.0% (0)
Gentamycin 0.0% (0) 0.0% (0) 8.3% (1) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
Nalidixic acid 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
Streptomycin 0.0% (0) 0.0% (0) 0.0% (0) 5.9% (2) 18.5% (5) 0.0% (0) 6.5% (2) 0.0% (0)
Tetracycline 0.0% (0) 0.0% (0) 8.3% (1) 8.8% (3) 22.2% (6) 0.0% (0) 41.9% (13) 0.0% (0)
Sulfisoxazole 5.3% (1) 3.7% (1) 0.0% (0) 5.9% (2) 22.2% (6) 20.0% (1) 6.5% (2) 0.0% (0)
Trimethoprim 0.0% (0) 3.7% (1) 0.0% (0) 5.9% (2) 11.1% (3) 0.0% (0) 6.5% (2) 0.0% (0)
with intestinal disease, while A is the group often associated with
commensal strains (37). Additionally, previous research indicates
that the majority of virulent extraintestinal strains belong to group
B2 (37). Virulent extraintestinal strains also belong to phyloge-
netic group D, but to a lesser degree (37). Our findings suggest
that NHPs carry E. coli belonging to multiple phylogenetic types,
and possibly multiple pathotypes, but whether or not these patho-
types are associated with disease in these animals is unknown at
this point.
Genes associated with all aforementioned pathotypes were
present among isolates in this NHP collection, but ExPEC-
associated genes were the most prevalent pathotype-associated
genes identified. ExPEC is best known for its role in causing uri-
nary tract infections (UTIs) and sepsis in human beings (60, 61).
However, it is unknown whether or not ExPEC causes disease in
NHPs. In terms of UTI pathogenesis, some evidence suggests that
monkeys are not suitable hosts for experimental infection mod-
els, as they do not appear to develop UTIs naturally from human
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ExPEC strains (60). Throughout the study period, none of the sub-
jects exhibited any clinical signs suggesting the presence of UTIs
or associated sepsis amongst the primate collection and therefore
it is more likely that these isolates were a component of the normal
GI flora of these animals.
Over the course of this study, all primate species examined,
aside from the orangutans, contained at least one isolate testing
positive for at least one of the diarrheagenic E. coli pathotypes
screened, including EPEC, ETEC, EAEC, EHEC, and EIEC. Of
these, EPEC-associated genes were the most prevalent. EPEC is a
major problem in developing countries because it is a major cause
of infant diarrhea, which is sometimes fatal (62). While no causa-
tion was established, it is certainly plausible that EPEC could play
a role in the intermittent diarrhea seen in this primate popula-
tion. It is likely that EPEC exhibits different effects on different
animals, with some animals acting as asymptomatic carriers and
others susceptible to diarrhea (3, 6, 7, 29).
As previously mentioned, we tested each E. coli isolate for
susceptibility toward the following seven antibiotics: ampicillin,
gentamicin, nalidixic acid, streptomycin, tetracycline, sulfisoxa-
zole, and trimethoprim. Past antibiotic treatments attempted at
the zoo to treat diarrheal illness have included ampicillin, tetracy-
cline, erythromycin, azithromycin, enrofloxacin, and sulfasalazine.
Recently, antibiotics were rarely used in the white-faced saki and
emperor tamarin populations, yet we observed a higher percentage
of resistance among the E. coli isolates obtained from these two
primate species (Table 5). In fact, neither the emperor tamarins
nor the white-faced sakis were treated with ampicillin, yet E. coli
isolated from the emperor tamarins showed the highest preva-
lence of ampicillin resistance (32.3%), and E. coli isolated from the
white-faced sakis showed the third highest prevalence of antibiotic
resistance (29.6%). Along these same lines, the emperor tamarins
were never treated with tetracycline, yet E. coli isolated from the
emperor tamarins showed the highest prevalence of tetracycline
resistance (41.9%) (Table 5). The fact that tetracycline resistance
and ampicillin resistance were high in the white-faced sakis and
emperor tamarins, while antibiotics were used infrequently, could
suggest that resistance genes carried by the obtained E. coli iso-
lates were not acquired in response to selective pressures. Another
plausible explanation is unknown co-selection may be occurring
through use of another antibiotic or antimicrobial agent. Also,
ampicillin has been used historically at the zoo to treat physical
injuries, which are often times incurred by the males. Specifically,
ampicillin has been the treatment of choice for the gorillas, orang-
utans, and spider monkeys. The proximity of the spider monkey
holding enclosure to the white-faced sakis and emperor tamarins
could be a factor in bacterial transmission, including isolates resis-
tant to ampicillin, as the same zoo staff member typically cleans
these three enclosures on a given day (Figure 2). Overall, the rates
of resistance observed in this study were much lower than those
observed in a previous study examining Snub-nosed monkeys at
zoos in China (63). This could be attributed to numerous fac-
tors, including geographical location, zoo practices, and primate
species examined.
In order to determine the genetic relatedness of E. coli over
time and between co-habitating (i.e., same primate complex) ani-
mal groups, sequence-based typing was performed on a subset of
the isolates using the fumC gene. The results of the sequence-based
typing indicated that E. coli strains of similar phylogenetic back-
grounds, harboring similar sets of virulence factors, are found in
multiple animals and species throughout the primate complex at
this zoo (Figure 1). This is reflected in the fumC sequence typ-
ing, where isolates often belonged to the same sequence types and
possessed similar virulence gene repertoires and plasmid types
(Figure 1). Specifically, common isolates were found between
spider monkeys and white-faced sakis, and between gorillas and
orangutans, among others.
One important factor to consider when considering potential
routes of bacterial transmission among the primates housed at the
Como Zoo’s primate complex is the layout of primate holding and
the system being employed at the time of this study for washing
enclosures, feeding, among other keeper-related tasks. In an effort
to visualize the potential routes of bacterial transmission from
different animal groups (i.e., primate species), we constructed a
detailed map of the primate complex showing the housing loca-
tions of all animal groups (i.e., primate species), as well as the
locations of doors and primate keeper areas (Figure 2). The map
provides perspective, as it allows for the visualization of where
each primate species is housed in relation to the others, including
those housed together, in close proximity, and at opposite sides of
the complex.
As previously mentioned, results of the sequence-based typing
showed that isolates with similar genetic backgrounds were found
between spider monkeys and white-faced sakis, and between goril-
las and orangutans, among others. As is illustrated in Figure 2,
the spider monkeys and white-faced sakis enclosures were phys-
ically separated, as were the gorillas and orangutans enclosures.
However, the gorillas and orangutans shared the same cleaning
equipment, as they were housed in close proximity to each other.
The same is true for the white-faced sakis and emperor tamarins.
In addition, the cleaning procedure at the zoo was designed so
that enclosures were located in relation to each other throughout
the complex, as well as the placement of cleaning equipment (e.g.,
hoses). This allows for one person to clean all enclosures located in
the great ape holdings section of the complex while another person
cleans the enclosures located in the small primate holdings section
of the complex simultaneously (Figure 2). Thus, on any given day,
the same keeper would be responsible for cleaning both the spi-
der monkeys and white-faced sakis enclosures (Figure 2). Due to
the cleaning system employed by the zoo, bacterial transmission
between animals likely occurred. One probable route of bacterial
transmission that could have taken place is via fomites; in this case,
water hoses, brushes, brooms, clothing, footwear, as well as other
primate keeper accessories and cleaning equipment could have
served as fomites. Overall, shared usage of cleaning equipment,
along with designating one keeper responsible for cleaning the
enclosures of multiple primate species simultaneously could have
resulted in the sharing of bacteria between physically separated
primates species.
Diarrhea in captive primates has long been a problem in both
zoo settings and research colonies, including the Como Zoo (22–
28). Diarrhea is a medical concern not only because it is phys-
iologically taxing to the animals, but also because it is an ideal
mechanism for disease transmission. This makes it both a public
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FIGURE 2 | Map of Como Zoo’s primate enclosure locations, including those in holding and on-exhibit. Species are colored as follows: gray=gorilla,
orange= orangutan, purple=De Brazza’s monkey, yellow= spider monkey, blue= lemur, green=Emperor tamarin, and red=white-faced saki and Geoffroy’s
tamarin.
health concern and an animal welfare concern. In this study,
we identified a number of E. coli isolates containing virulence
genes from various pathotypes, and there was evidence of clonal
transmission of isolates between animals and over time in the com-
plex. Overall, the manifestation of chronic diarrhea in the Como
Zoo’s primate collection is a complex problem whose solution
will require regular screening for microbial agents and considera-
tion of environmental causes. The use of E. coli as a surrogate for
pathogen transmission, in this setting, aids in the identification of
approaches that can be used in captive NHP populations to reduce
such transmission.
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